Role Of Colposcopy In Evaluation Of Suspicious Cervix
ConditionCancer Cervix
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-60
SponsorSohag University
About this trial
do colposcopy and cervical punch biopsy then compare between findings
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age from 30 to 64 years old.
Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding.
Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization)
Women with Pap smear showing dysplasia
Disqualifiers
Pregnant women
Women having active vaginal bleeding.
Any past treatment for cervical lesions.
Women having frank growth of cervix.
Trial population
* Age from 30 to 64 years old. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia.
Trial design
Design model
Case-crossover
Time perspective
Cross-sectional
Treatments tested in this trial
Do colposcopy and cervical punch biopsy then compare between findings
DeviceThe aim of this study is to correlate colposcopy and histopathological findings in early screening of suspicious cervix and cervical cancer. And to do a colposcopic evaluation of all cervical lesions and the early detection of all cervical precancer and invasive lesions of the cervix in symptomatic women.
Treatment groups
53 Participants
are divided into 1 treatment groupGroup A: colposcopic evaluation1 intervention
Trial outcomes
Primary outcomes
1
comparison between colposcopic findings of suspicious cervix and histopathologic findings
Correlate colposcopy and histopathological findings in early screening of suspicious cervix and cervical cancer. And to do a colposcopic evaluation of all cervical lesions and the early detection of all cervical precancer and invasive lesions of the cervix in symptomatic women.
Time frame
baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov